PK and PD of GSK-2292767A, a novel low-solubility inhaled phosphoinositide 3-kinase delta inhibitor July 30, 2019 No Comments
Synairgen updates phase II progress with inhaled IFN-beta in patients with COPD July 24, 2019 No Comments
Bellus Health initiates phase II trial of BLU-5937 for unexplained or refractory chronic cough July 18, 2019 No Comments
Novel collagen-targeted PET tracer: safety, distribution and detection of collagen deposition in IPF July 11, 2019 No Comments
RSS